{"id":61723,"date":"2025-08-13T19:05:29","date_gmt":"2025-08-13T17:05:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/"},"modified":"2025-08-13T19:05:29","modified_gmt":"2025-08-13T17:05:29","slug":"flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/","title":{"rendered":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Flatiron\u2019s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer<\/i><\/li>\n<\/ul>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Barcelona, Spain.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/5\/Flatiron_Horizontal_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/5\/Flatiron_Horizontal_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/21\/Flatiron_Horizontal_RGB.jpg\"><\/a><\/p>\n<p>\n\u201cAI is a transformative force enabling scale, speed, and novel insights that were previously impossible. By harnessing advanced AI across our global network of more than five million people with cancer, we\u2019re setting a new standard for real-world data at scale,\u201d said Nathan Hubbard, Chief Business Officer, Flatiron Health. \u201cOur research at this year\u2019s World Conference on Lung Cancer exemplifies how high-quality, multimodal real-world data combined with responsible AI practices can illuminate treatment patterns, measure effectiveness, and reveal where innovation is most urgently needed.\u201d<\/p>\n<p>\nA highlight of Flatiron\u2019s presence at WCLC 2025 is the first published research leveraging the Flatiron Health\u2013Caris Life Sciences Clinical-Molecular Database (CMDB), the largest and most robust multimodal dataset of its kind, to identify a novel gene signature that predicts risk of liver metastasis in patients with advanced non-small cell lung cancer (NSCLC). By integrating high-quality clinical data with comprehensive molecular profiling, the research addresses a critical unmet need\u2014providing clinicians with a new tool to identify high-risk patients and potentially enable more personalized surveillance and treatment strategies.<\/p>\n<p>\nAdditional highlights include:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\na poster highlighting ongoing gaps in biomarker testing after assessing over 13,000 patients with NSCLC in the US and UK<\/li>\n<li>\na poster providing new insights into how NSCLC is managed in the UK, including details on the most commonly used treatments, patterns in biomarker testing, and overall survival outcomes<\/li>\n<\/ul>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fevents.flatiron.com%2Fwclc-2025&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Schedule+a+meeting+with+Flatiron+Health+at+WCLC+2025&amp;index=1&amp;md5=a5eae062bc822a625a231fd2a253c808\" rel=\"nofollow\" shape=\"rect\">Schedule a meeting with Flatiron Health at WCLC 2025<\/a> and follow Flatiron Health on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2Fflatironhealth&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=X&amp;index=2&amp;md5=7b1f55c0b73badf1b8b0262d361ca83f\" rel=\"nofollow\" shape=\"rect\">X<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fflatiron-health%2F&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=78c4166584e513ae3766aaa53cf36bf4\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a> for more updates from #WCLC25.<\/p>\n<p>\n<b><span class=\"bwuline\">Abstracts and Poster Presentations<br \/>\n<br \/><\/span><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Fa-novel-predictive-gene-signature-for-liver-metastasis-lm-in-nsclc-using-a-comprehensive-linked-clinical-molecular-database&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=A+Novel+Predictive+Gene+Signature+for+Liver+Metastasis+%28LM%29+in+NSCLC+Using+a+Comprehensive+Linked+Clinical-Molecular+Database&amp;index=4&amp;md5=9c9a5ea61b571b9df84369fc0f197773\" rel=\"nofollow\" shape=\"rect\"><b>A Novel Predictive Gene Signature for Liver Metastasis (LM) in NSCLC Using a Comprehensive Linked Clinical-Molecular Database<\/b><\/a><b><br \/><\/b><i>Partner: Caris Life Sciences<br \/>\n<br \/><\/i>Poster<br \/>\n<br \/>Session: P2.06 &#8211; Pathology and Biomarkers<br \/>\n<br \/>Presentation Number: P2.06.45<br \/>\n<br \/>Location: Exhibit Hall<br \/>\n<br \/>Session Start\/End: Monday, September 8, 10:30AM &#8211; 12PM<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Freal-world-biomarker-testing-and-treatment-initiation-in-patients-with-resected-early-stage-nsclc-ensclc-in-the-us-and-uk&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Real-world+Biomarker+Testing+and+Treatment+Initiation+in+Patients+with+Resected+Early-stage+NSCLC+%28eNSCLC%29+in+the+US+and+UK&amp;index=5&amp;md5=2fa6c9a05a379b45482ed47792a7b354\" rel=\"nofollow\" shape=\"rect\"><b>Real-world Biomarker Testing and Treatment Initiation in Patients with Resected Early-stage NSCLC (eNSCLC) in the US and UK<\/b><\/a><b><br \/><\/b>Poster<br \/>\n<br \/>Session: P1.07 &#8211; Early-Stage Non-small Cell Lung Cancer<br \/>\n<br \/>Presentation Number: P1.07.05<br \/>\n<br \/>Location: Exhibit Hall<br \/>\n<br \/>Session Start\/End: September 7, 10:30AM &#8211; 12PM<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Freal-world-outcomes-of-prophylactic-cranial-irradiation-in-extensive-stage-small-cell-lung-cancer-treated-with-first-line-immunotherapy-and-platinum-etoposide&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Real-World+Outcomes+of+Prophylactic+Cranial+Irradiation+in+Extensive-Stage+Small+Cell+Lung+Cancer+Treated+with+First-Line+Immunotherapy+and+Platinum-Etoposide&amp;index=6&amp;md5=1cc67876a6fa0fe92ab46c8bacdb891e\" rel=\"nofollow\" shape=\"rect\"><b>Real-World Outcomes of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer Treated with First-Line Immunotherapy and Platinum-Etoposide<\/b><\/a><b><br \/><\/b>Poster<br \/>\n<br \/>Session: P3.13 &#8211; Small Cell Lung Cancer and Neuroendocrine Tumors<br \/>\n<br \/>Presentation Number: P3.13.10<br \/>\n<br \/>Location: Exhibit Hall<br \/>\n<br \/>Session Start\/End: September 9, 10 &#8211; 11:30AM<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Freal-world-survival-outcomes-in-non-small-cell-lung-cancer-insights-from-uk-ehr&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Real-World+Survival+Outcomes+in+Non%26%238211%3BSmall+Cell+Lung+Cancer%3A+Insights+from+UK+EHR-Derived+Data&amp;index=7&amp;md5=b5081c63f0d19a099eb5d897905fc86a\" rel=\"nofollow\" shape=\"rect\"><b>Real-World Survival Outcomes in Non\u2013Small Cell Lung Cancer: Insights from UK EHR-Derived Data<\/b><\/a><b><br \/><\/b>E-Poster<br \/>\n<br \/>Session: EP.17 &#8211; Global Health, Health Services, and Health Economics<br \/>\n<br \/>Presentation Number: EP.17.34<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Fdisease-burden-and-rwpfs-as-a-surrogate-endpoint-for-rwos-in-ntrk-nsclc-and-other-advanced%2Fmetastatic-solid-tumor&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Disease+Burden+and+rwPFS+as+a+Surrogate+Endpoint+for+rwOS+in+NTRK%2B+NSCLC+and+Other+Advanced%2FMetastatic+Solid+Tumors&amp;index=8&amp;md5=ef5d8ea0e0d515446603398878db9118\" rel=\"nofollow\" shape=\"rect\"><b>Disease Burden and rwPFS as a Surrogate Endpoint for rwOS in NTRK+ NSCLC and Other Advanced\/Metastatic Solid Tumors<\/b><\/a><b><br \/><\/b><i>Partners: Bristol-Myers Squibb, University of Colorado Cancer Center<br \/>\n<br \/><\/i>E-poster<br \/>\n<br \/>Session: EP.12 &#8211; Metastatic Non-small Cell Lung Cancer \u2013 Targeted Therapy<br \/>\n<br \/>Presentation Number: EP.12.23<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Freal-world-treatment-patterns-in-es-sclc-highlight-continued-unmet-medical-need-in-the-era-of-new-therapies-essence-study&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Real-World+Treatment+Patterns+in+ES-SCLC+Highlight+Continued+Unmet+Medical+Need+in+the+Era+of+New+Therapies%3A+ESSENCE+Study&amp;index=9&amp;md5=440f9df97ac408202dce005676c87492\" rel=\"nofollow\" shape=\"rect\"><b>Real-World Treatment Patterns in ES-SCLC Highlight Continued Unmet Medical Need in the Era of New Therapies: ESSENCE Study<\/b><\/a><b><br \/><\/b><i>Partners: Montefiore Medical Center, GSK, Rush University<br \/>\n<br \/><\/i>E-poster<br \/>\n<br \/>Session: EP.13 &#8211; Small Cell Lung Cancer and Neuroendocrine Tumors<br \/>\n<br \/>Presentation Number: EP.13.25<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Fevolving-treatment-patterns-in-early-stage-non-small-cell-lung-cancer-in-the-us&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Evolving+Treatment+Patterns+in+Early-Stage+Non-Small+Cell+Lung+Cancer+in+the+United+States&amp;index=10&amp;md5=9010c678ad6d857e26e9962ac3785ce0\" rel=\"nofollow\" shape=\"rect\"><b>Evolving Treatment Patterns in Early-Stage Non-Small Cell Lung Cancer in the United States<\/b><\/a><b><br \/><\/b><i>Partners: Lilly<br \/>\n<br \/><\/i>E-poster<br \/>\n<br \/>Session: EP.17 &#8211; Global Health, Health Services, and Health Economics<br \/>\n<br \/>Presentation Number: EP.17.33<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fresources.flatiron.com%2Fpublications%2Freal-world-treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-neuroendocrine-neoplasms-of-the-lung-nen-l&amp;esheet=54307901&amp;newsitemid=20250813223582&amp;lan=en-US&amp;anchor=Real-World+Treatment+Patterns+and+Clinical+Outcomes+in+Patients+With+Metastatic+Neuroendocrine+Neoplasms+of+the+Lung+%28NEN-L%29&amp;index=11&amp;md5=45607d91396d8807b5a20c87cfd2e2bc\" rel=\"nofollow\" shape=\"rect\"><b>Real-World Treatment Patterns and Clinical Outcomes in Patients With Metastatic Neuroendocrine Neoplasms of the Lung (NEN-L)<\/b><\/a><b><br \/><\/b><i>Partners: Merck &amp; Co<br \/>\n<br \/><\/i>E-poster<br \/>\n<br \/>Session: EP.13 &#8211; Small Cell Lung Cancer and Neuroendocrine Tumors<br \/>\n<br \/>Presentation Number: EP.13.44<\/p>\n<p>\n<b>About Flatiron<br \/>\n<br \/><\/b>Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients\u2019 real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nNina Toor<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#112;&#x72;&#x65;s&#115;&#64;&#x66;&#x6c;at&#105;&#x72;&#x6f;&#x6e;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x70;&#114;e&#x73;&#115;&#64;&#x66;&#x6c;&#97;t&#x69;&#114;o&#x6e;&#x2e;&#99;o&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Flatiron\u2019s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer NEW YORK&#8211;(BUSINESS WIRE)&#8211;Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61723","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Flatiron\u2019s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer NEW YORK&#8211;(BUSINESS WIRE)&#8211;Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-13T17:05:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer\",\"datePublished\":\"2025-08-13T17:05:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/\"},\"wordCount\":719,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250813223582\\\/en\\\/2552324\\\/22\\\/Flatiron_Horizontal_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/\",\"name\":\"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250813223582\\\/en\\\/2552324\\\/22\\\/Flatiron_Horizontal_RGB.jpg\",\"datePublished\":\"2025-08-13T17:05:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250813223582\\\/en\\\/2552324\\\/22\\\/Flatiron_Horizontal_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250813223582\\\/en\\\/2552324\\\/22\\\/Flatiron_Horizontal_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend","og_description":"Flatiron\u2019s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer NEW YORK&#8211;(BUSINESS WIRE)&#8211;Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-13T17:05:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer","datePublished":"2025-08-13T17:05:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/"},"wordCount":719,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/","url":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/","name":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg","datePublished":"2025-08-13T17:05:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250813223582\/en\/2552324\/22\/Flatiron_Horizontal_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61723"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61723\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}